Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Gasperini

Showing results (31-40 of 94) with videos related to

Pageof 10
Sort By:
Journal of Neurology, Neurosurgery, and Psychiatry|April 14, 1999
Statistical power of MRI monitored trials in multiple sclerosis: new data and comparison with previous resultsM P Sormani, P D Molyneux, C Gasperini, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 5, 1998
Determinants of Gd-enhanced MRI response to IFN-beta-1a treatment in relapsing-remitting multiple sclerosisT Koudriavtseva, C Pozzilli, M Fiorelli, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 7, 2002
MRI brain volume changes in relapsing-remitting multiple sclerosis patients treated with interferon beta-1aC Gasperini, A Paolillo, E Giugni, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 1, 1997
MRI measures and their relations with clinical disability in relapsing-remitting and secondary progressive multiple sclerosisE Giugni, C Pozzilli, S Bastianello, et al.
Journal of the Neurological Sciences|March 23, 2000
Brain atrophy in relapsing-remitting multiple sclerosis: relationship with 'black holes', disease duration and clinical disabilityA Paolillo, C Pozzilli, C Gasperini, et al.
Journal of Neurology|August 4, 1999
Magnetic resonance imaging outcome of new enhancing lesions in relapsing-remitting multiple sclerosis patients treated with interferon beta1aA Paolillo, S Bastianello, M Frontoni, et al.
European Journal of Neurology|November 29, 2013
Diagnostic problems in "clinically definite" multiple sclerosis patients with normal CSF and multiple MRI abnormalitiesC Fieschi, C Gasperini, G Ristori, et al.
Neuroradiology|May 1, 1996
High-dose contrast-enhanced MRI in multiple sclerosisT Koudriavtseva, C Pozzilli, C Di Biasi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 1, 2000
Contrast-enhanced magnetic resonance activity in relapsing remitting multiple sclerosis patients: a short term natural history studyF Bagnato, A Tancredi, N Richert, et al.
AJNR. American Journal of Neuroradiology|February 12, 1999
Interscanner variation in brain MR lesion load measurements in multiple sclerosis using conventional spin-echo, rapid relaxation-enhanced, and fast-FLAIR sequencesM Filippi, M A Rocca, C Gasperini, et al.
Pageof 10

Showing results (31-40 of 94) with videos related to

Sort By:
Pageof 10
Journal of Neurology, Neurosurgery, and Psychiatry|April 14, 1999
Statistical power of MRI monitored trials in multiple sclerosis: new data and comparison with previous resultsM P Sormani, P D Molyneux, C Gasperini, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 5, 1998
Determinants of Gd-enhanced MRI response to IFN-beta-1a treatment in relapsing-remitting multiple sclerosisT Koudriavtseva, C Pozzilli, M Fiorelli, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 7, 2002
MRI brain volume changes in relapsing-remitting multiple sclerosis patients treated with interferon beta-1aC Gasperini, A Paolillo, E Giugni, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 1, 1997
MRI measures and their relations with clinical disability in relapsing-remitting and secondary progressive multiple sclerosisE Giugni, C Pozzilli, S Bastianello, et al.
Journal of the Neurological Sciences|March 23, 2000
Brain atrophy in relapsing-remitting multiple sclerosis: relationship with 'black holes', disease duration and clinical disabilityA Paolillo, C Pozzilli, C Gasperini, et al.
Journal of Neurology|August 4, 1999
Magnetic resonance imaging outcome of new enhancing lesions in relapsing-remitting multiple sclerosis patients treated with interferon beta1aA Paolillo, S Bastianello, M Frontoni, et al.
European Journal of Neurology|November 29, 2013
Diagnostic problems in "clinically definite" multiple sclerosis patients with normal CSF and multiple MRI abnormalitiesC Fieschi, C Gasperini, G Ristori, et al.
Neuroradiology|May 1, 1996
High-dose contrast-enhanced MRI in multiple sclerosisT Koudriavtseva, C Pozzilli, C Di Biasi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 1, 2000
Contrast-enhanced magnetic resonance activity in relapsing remitting multiple sclerosis patients: a short term natural history studyF Bagnato, A Tancredi, N Richert, et al.
AJNR. American Journal of Neuroradiology|February 12, 1999
Interscanner variation in brain MR lesion load measurements in multiple sclerosis using conventional spin-echo, rapid relaxation-enhanced, and fast-FLAIR sequencesM Filippi, M A Rocca, C Gasperini, et al.
Pageof 10